Italia markets close in 3 hours 57 minutes

PCI Biotech Holding ASA (0JGL.L)

LSE - LSE Prezzo differito. Valuta in NOK.
Aggiungi a watchlist
2,5900-1,4900 (-36,52%)
Al 11:09AM GMT. Mercato aperto.
Schermo intero
Chiusura precedente4,2520
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,0000 - 0,0000
Intervallo di 52 settimane
Media VolumeN/D
Beta (5 anni mensile)1,76
Rapporto PE (ttm)N/D
EPS (ttm)-2,3480
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    PCI Biotech: Employee share option scheme

    Oslo, 25 November 2022 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In accordance with the authorisation granted by the Annual General Meeting 25 May 2022 and the remuneration policy adopted by the Annual General Meeting 28 May 2021, the Board of Directors of PCI Biotech Holding ASA (“PCI Biotech”) has awarded a total of 570,000 share options to key employees. Each share option gives the right to subscribe for or acquire one sh

  • GlobeNewswire

    PCI Biotech interim Q3 2022 report

    Oslo (Norway), 23 November 2022 – PCI Biotech (OSE: PCIB), today announces its interim Q3 2022 results. Please find enclosed the report and presentation. Highlights Corporate*Efforts to finance a Ph II clinical trial in head and neck cancer did not, under the current market conditions, result in a feasible way forward and the company reported in August that it will not conduct a company-sponsored Ph II trial with the fimaVacc technology. This entailed a downsizing of the clinical team, which is

  • GlobeNewswire

    PCI Biotech: Invitation to Q3 2022 results presentation

    Oslo, Norway, 17 November 2022 - PCI Biotech (OSE: PCIB) invites to an online presentation of the company's Q3 2022 interim report on Wednesday 23 November 2022, 08:30am – 09:30am CET (local time). The presentation will be held as a live webcast and can be accessed through There will be a Q&A session at the end of the presentation and it will be possible to post written questions through the webcast console or through a teleconference facilitated for attendees intending to as